Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis. J of Skin 2024, 8 (2), s373. https://doi.org/10.25251/skin.8.supp.373.